drugset / Trial / NCT04757675
S-ketamin Premedication in Pediatric EENT Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
We aim to investigate the effects of premedication (intranasal or intravenous administration) of s-ketamin, dexmedetomidine, and combination for premedication in children undergoing ENT surgery.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2021-09-01
- Completion
- 2022-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intranasal |
| Subject | Dexmedetomidine | Other / unclassified | 2 ug/kg | Intranasal |
| Subject | Esketamine | Other / unclassified | 0.3 ug/kg | Intravenous |
| Subject | Esketamine | Other / unclassified | 0.5 ug/kg | Intravenous |
| Subject | Esketamine | Other / unclassified | 1 ug/kg | Intravenous |
| Subject | Esketamine | Other / unclassified | 2 ug/kg | Intravenous |